SCHEMBL13896249

SCHEMBL13896249

NC(=O)CS(=O)(=O)C1CCc2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.51
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
MAOA P21397 3/20 0.44
MAOB P27338 3/20 0.44
PIN1 Q13526 1/20 0.39
IDO1 P14902 2/20 0.39
HSD11B1 P28845 1/20 0.39
RET P07949 1/20 0.38
HTR2A P28223 1/20 0.38
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.37
BCHE P06276 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37
ACHE P22303 1/20 0.37
ADRA1A P35348 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13896218 0.85 HTR6 (0.48) HTR6CA1CA2MAOAMAOB
SCHEMBL9662668 0.76 HTR6 (0.51) HTR6CA1CA2MAOAMAOB
SCHEMBL731798 0.75 HTR6 (0.61) HTR6CA1CA2MAOAMAOB
SCHEMBL2319101 0.75 HTR6 (0.57) HTR6CA1CA2MAOAMAOB
SCHEMBL3243357 0.75 HTR6 (0.50) HTR6CA1CA2MAOAMAOB
SCHEMBL29207366 0.74 HTR6 (0.55) HTR6CA1CA2MAOAMAOB
Hydrochloric Acid SCHEMBL27814998 0.74 HTR6 (0.59) HTR6CA1CA2MAOAMAOB
SCHEMBL2026702 0.72 HTR6 (0.57) HTR6CA1CA2MAOAMAOB
SCHEMBL16242806 0.72 HTR6 (0.57) HTR6CA1CA2MAOAMAOB
SCHEMBL4714587 0.71 HTR6 (0.51) HTR6CA1CA2PIN1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745015-B1 BICYCLIC AROMATIC SULFINYL DERIVATIVES CEPHALON INC (US) 2016-02-17 EP disclosed
US-8314155-B2 Bicyclic aromatic sulfinyl derivatives CEPHALON, INC (US) 2012-11-20 US disclosed
US-8314155-B2 Bicyclic aromatic sulfinyl derivatives CEPHALON, INC (US) 2012-11-20 US disclosed
US-20090042907-A1 Bicyclic aromatic sulfinyl derivatives CEPHALON, INC. (US) 2009-02-12 US disclosed
US-20090042907-A1 Bicyclic aromatic sulfinyl derivatives CEPHALON, INC. (US) 2009-02-12 US disclosed
US-7423176-B2 Bicyclic aromatic sulfinyl derivatives CEPHALON, INC. (US) 2008-09-09 US disclosed
US-7423176-B2 Bicyclic aromatic sulfinyl derivatives CEPHALON, INC. (US) 2008-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042907-A1 Bicyclic aromatic sulfinyl derivatives SULT2A1, TPST2, AHR HTR6 216/4885CA1 4740/4885CA2 4231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.